The results of the Transwell invasion assay aligned with those of the migration assay (p < 0.05), demonstrating that silencing PRNP enhances the inhibitory effect of gemcitabine on pancreatic cancer cell invasion (Figures 7C–F). Here, PRNP is linked to familial pancreatic carcinoma.